Valproate use and thyroid dysfunction in children with idiopathic epilepsy
Journal Title: Paediatrica Indonesiana - Year 2018, Vol 58, Issue 4
Abstract
Background Long-term administration of valproic acid (VPA) has side effects, including thyroid dysfunction. Subclinical hypothyroidism (SCH) identified by elevated serum thyroid stimulating hormone (TSH) concentrations with normal thyroxine (T4) and triiodothyronine (T3), or normal free thyroxine (fT4) and free triiodothyronine (fT3) has been demonstrated in idiopathic epilepsy patients receiving VPA. Objective To evaluate for associations between age at initiation of VPA treatment and duration of treatment with thyroid dysfunction. Methods A cross-sectional study was conducted from October 2012 to May 2013 in Haji Adam Malik and Pirngadi Hospitals, Medan, North Sumatera. Subjects were children ranging from 0 and below 18 years who had been diagnosed with idiopathic epilepsy. Blood specimens were taken to evaluate serum T3, T4, and TSH levels in all subjects. Data were analyzed using bivariate and multivariate analyses. Results A total of 49 subjects were included in the study. Age of ≤ 4 years at initiation of VPA was found to be a significant risk factor for SCH in the bivariate analysis (OR 6.67; 95%CI 1.215 to 36.594, P=0.036). Three factors had P values <0.25 in the bivariate analysis and were subsequently analyzed by stepwise multivariate regression test: age at initiation of VPA, duration of treatment, and drug dosage. The VPA initiation at age <4 years had 6.67 times the risk of SCH than the age of >4 years (95%CI 1.215 to 36.594; P=0.029). Duration of treatment and VPA dosage were not significantly associated with SCH on multivariate analysis Conclusion Age ≤ 4 years old at the initiation of VPA is associated with thyroid dysfunction. However, no significant association was found between duration of treatment as well as drug dosage with thyroid dysfunction.
Authors and Affiliations
Josephine Sibarani, Melda Deliana, Johannes Saing
Keywords
Related Articles
- EP ID EP508828
- DOI 10.14238/pi58.4.2018.192-7
- Views 108
- Downloads 0
Iron profiles of preterm infants at two months of chronological age
Background Preterm infants are vulnerable to iron deficiency (ID) due to lack of maternal iron stores, repeated phlebotomy, and the body’s increased demand for iron during growth. The risk of ID increases at 2 months of...
The effect of cyanotic and acyanotic congenital heart disease on children’s growth velocity
Background Congenital heart disease (CHD) can lead to failure to thrive. Decreased energy intake, malabsorption, increased energy requirements, and decreased growth factors (growth hormone/insulin-like growth factor 1 ax...
Anemia among children and adolescents in a rural area
Background Anemia in children and adolescents affects growthand development. It is a preventable disease, but unfortunately isoften ignored until the symptoms occur. There have been limitedreports on the prevalence of an...
The effect of regular aerobic exercise on urinary brain-derived neurotrophic factor in children
Background Nervous system development in early lifeinfluences the quality of cognitive ability during adulthood.Neuronal development and neurogenesis are highly influencedby neurotrophins. The most active neurotrophin is...
Developmental performance in small for gestational age children with and without catch-up growth
Background Infants born small for gestational age (SGA) have an increased risk of developmental delay. The influence of catch-up growth on developmental function remains unknown.Objective To compare the development of SG...